Insulin clinical trials

FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)

This study looks at a new drug called frexalimab for people aged 12-35 newly diagnosed with Type 1 Diabetes. It aims to see if frexalimab, taken alongside insulin, can help the body keep making its own insulin. Half the participants will get frexalimab, and half a dummy medicine.